The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs-Reference-Cited by-同舟云学术

The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs

Published:2022-09 Issue: Volume:312 Page:225-234
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Fugger Gernot,Bartova Lucie,Fabbri Chiara,Fanelli Giuseppe,Zanardi Raffaella,Dold Markus,Kautzky Alexander,Rujescu Dan,Souery Daniel,Mendlewicz Julien,Zohar Joseph,Montgomery Stuart,Serretti Alessandro,Kasper Siegfried

Funder

H. Lundbeck A/S

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference76 articles.

1. Mirtazapine in inpatient treatment of depressed patients;Bailer;Wien. Klin. Wochenschr.,1998

2. Results of the european Group for the Study of resistant depression (GSRD) - basis for further research and clinical practice;Bartova;World J. Biol. Psychiatry,2019

4. Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the european Group for the Study of resistant depression;Bartova;J. Psychiatr. Res.,2021

5. Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines;Bauer;Int. J. Psychiatry Clin. Pract,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder;Journal of Affective Disorders;2023-07

2. Association of anhedonia and suicidal ideation in patients with treatment-refractory depression after intravenous ketamine infusions;International Journal of Psychiatry in Clinical Practice;2022-10-29